News
TXMD
1.860
-1.59%
-0.030
Weekly Report: what happened at TXMD last week (0408-0412)?
Weekly Report · 5d ago
Weekly Report: what happened at TXMD last week (0401-0405)?
Weekly Report · 04/08 09:28
Weekly Report: what happened at TXMD last week (0325-0329)?
Weekly Report · 04/01 09:27
TherapeuticsMD Announces 2023 Annual Financial Results
TherapeuticsMD, Inc. Announced its annual financial results for 2023 on March 29, 2024. The results are for informational purposes and should not be considered official. The company is expected to report its financial results in April of this year. The stock is currently trading at $16.50.
TipRanks · 03/29 20:43
Therapeutics MD reports FY results
TherapeuticsMD, Inc. Reports FY results Mar. 29, 2024 4:21 p.m. ET. The company's net loss from continuing operations was $7.7 million. Gross license royalties totaled about $4.5 million for the full year of 2023.
Seeking Alpha · 03/29 20:21
*TherapeuticsMD: Evaluation of Strategic Alternatives Continues >TXMD
Dow Jones · 03/29 20:01
Press Release: TherapeuticsMD Announces Full Year 2023 Financial Results
TherapeuticsMD Announces Full Year 2023 Financial Results for the full year ended December 31, 2023. The company owns rights to pharmaceutical royalties. Gross license royalties totaled approximately $4.5 million for the year. The Company continues to explore a variety of strategic alternatives.
Dow Jones · 03/29 20:00
*TherapeuticsMD 2023 Cont Ops Loss/Shr 74c >TXMD
Dow Jones · 03/29 20:00
Weekly Report: what happened at TXMD last week (0318-0322)?
Weekly Report · 03/25 09:28
Weekly Report: what happened at TXMD last week (0311-0315)?
Weekly Report · 03/18 09:28
Weekly Report: what happened at TXMD last week (0304-0308)?
Weekly Report · 03/11 09:27
5 Value Stocks In The Healthcare Sector
A value stock traditionally has a lower price when compared to companies in the same industry. This indicates that the company may be undervalued. The most commonly used way to check for value is with the price-to-earnings multiple, or P/E. The following stocks are considered to be notable value stocks in the healthcare sector.
Benzinga · 03/04 14:44
Weekly Report: what happened at TXMD last week (0226-0301)?
Weekly Report · 03/04 09:28
Weekly Report: what happened at TXMD last week (0219-0223)?
Weekly Report · 02/26 09:30
Weekly Report: what happened at TXMD last week (0212-0216)?
Weekly Report · 02/19 09:31
Overview Of Value Stocks In The Healthcare Sector
A value stock is traditionally defined in terms of how investors are valuing a company's future growth prospects. Low P/E multiples are good indicators that a company is undervalued. Benzinga Insights has selected five notable value stocks in the healthcare sector. These 5 value stocks were selected based on quantified analysis.
Benzinga · 02/12 14:43
Weekly Report: what happened at TXMD last week (0205-0209)?
Weekly Report · 02/12 09:28
Weekly Report: what happened at TXMD last week (0129-0202)?
Weekly Report · 02/05 09:30
Weekly Report: what happened at TXMD last week (0122-0126)?
Weekly Report · 01/29 09:28
Weekly Report: what happened at TXMD last week (0115-0119)?
Weekly Report · 01/22 09:29
More
Webull provides a variety of real-time TXMD stock news. You can receive the latest news about Therapeuticsmd Inc through multiple platforms. This information may help you make smarter investment decisions.
About TXMD
TherapeuticsMD, Inc. is a healthcare company. The Company is focused on developing and commercializing products exclusively for women. It is engaged in conducting business by out-licensing its products and collecting royalties, after granting a license to commercialize the Company's IMVEXXY, BIJUVA, and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands in the United States and its possessions and territories and assigning the Company’s exclusive license to commercialize ANNOVERA in the United States and its possessions and territories to Mayne Pharma. ANNOVERA is a one-year (13 cycles) ring-shaped contraceptive vaginal system (CVS)). ANNOVERA, which is made with a silicone elastomer, contains segesterone acetate, a 19-nor progesterone derivative also known as Nestorone (SA) and ethinyl estradiol (EE). Its menopause portfolio includes IMVEXXY and BIJUV. IMVEXXY (estradiol vaginal inserts) for the treatment of moderate-to-severe dyspareunia.